Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.

Product Documentation

Details, specifications, and documents

Description

Gonadorelin 2 mg: research material

Buy Gonadorelin 2 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

Gonadorelin is a synthetic decapeptide corresponding to gonadotropin-releasing hormone, or GnRH. Its ten-residue structure makes it a defined material for investigating pituitary signaling and peptide structure-activity relationships.

Choose the material and presentation

This 2 mg listing is Gonadorelin research peptide in dry form. It is not a sublingual tablet or a prepared clinical formulation. The amount per vial describes labeled material mass, while 3 mL describes the container capacity; neither is a solution concentration.

Check the complete sequence, terminal chemistry and supplied chemical form when matching an experimental method. Modified GnRH agonists and antagonists are separate constructs. A salt designation in another supplier’s listing does not identify the form of this product.

Gonadorelin structure and GnRH signaling research

How the reference structure was established

Burgus and colleagues characterized ovine luteinizing hormone-releasing factor using enzymatic cleavage, sequencing and mass spectrometry. A synthesized decapeptide produced the same sequence result and the reported biological activities of the native material.

The reference has a pyroglutamyl N-terminus and an amidated C-terminus. Those structural features matter when comparing peptides; they should not be replaced by a name-only match. The study establishes molecular identity, rather than a clinical outcome from a catalog vial.

Read the original structure study

Exposure pattern changes the experimental question

Haisenleder and colleagues compared pulsatile and continuous GnRH exposure in a controlled rat model. They measured gonadotropin-subunit gene transcription in isolated pituitary nuclei. Responses depended on timing and differed between transcription measurements and cytoplasmic messenger RNA.

This is a reason to record exposure pattern and endpoint when comparing research findings. A result for LH or FSH gene expression is not interchangeable with a measurement of hormone release, and it does not establish fertility or testosterone benefits for this product.

Read the original pulse-pattern study

Product records and batch reports

Review available batch reports and files in the product documentation section. Match the product and lot before interpreting a certificate of analysis (COA). Identity, chromatographic purity and measured content answer different questions and should be read separately.

Use the applicable material records for storage and handling. A published signaling experiment does not verify this lot’s solubility, shelf life or suitability for an assay.

Additional information

CAS No.

33515-09-2

Purity

≥99%

Sequence

pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2

Molecular Formula

C55H75N17O13

Molecular Weight

1182.31 g/mol

Applications

In-vitro assay research, compound characterization, analytical method development

Synthesis

Solid-phase synthesis

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C.

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received, store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

Safety Information

Refer to provided MSDS

COA & Documents

Independent lot testing

Gonadorelin 2mg Certificate of Analysis

This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.

Lot number
35188
Report number
39812
Date tested
September 15, 2026
Reported purity
99.359%
Labeled content
2 mg
DOWNLOADABLE RESOURCES

Product documents

Product information and laboratory resources. For lot-specific results, use the COA above.

PDF

Product & packaging information

Labeled amount, physical form and packaging for Gonadorelin 2mg.

Revision 0.4 · 2026-10-05Download PDF
PDF

Laboratory handling guide

General guidance for applicable lyophilized research materials. Not a product-specific SDS.

Revision 1.0 · 2026-09-22Download PDF
General guides & resources

Need Assistance?

Questions about product documentation?

Contact our support team for help with product records, lot information, orders or certificate verification.

Contact Support